54 related articles for article (PubMed ID: 23359065)
21. 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis.
Orimo S; Suzuki M; Inaba A; Mizusawa H
Parkinsonism Relat Disord; 2012 Jun; 18(5):494-500. PubMed ID: 22321865
[TBL] [Abstract][Full Text] [Related]
22. Influence of myocardial region of interest definition on quantitative analysis of planar 123I-mIBG images.
Jacobson AF; Matsuoka DT
Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):558-64. PubMed ID: 23359065
[TBL] [Abstract][Full Text] [Related]
23. ¹²³I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity.
Verschure DO; de Wit TC; Bongers V; Hagen PJ; Sonneck-Koenne C; D'Aron J; Huber K; van Eck-Smit BL; Knoll P; Somsen GA; Mirzaei S; Verberne HJ
Nucl Med Commun; 2015 Mar; 36(3):279-85. PubMed ID: 25415845
[TBL] [Abstract][Full Text] [Related]
24. [Assessment of most appropriate background subtraction method for quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake by comparing with plasma ANP and BNP].
Yahara Y; Nomura Y; Okamoto S; Saitou K; Okamoto R; Makino K; Aoki S; Takeda K
Kaku Igaku; 2000 May; 37(3):217-25. PubMed ID: 10860352
[TBL] [Abstract][Full Text] [Related]
25. Quantification and Determination of Normal
Alvi R; Miller EJ; Zonouz TH; Sandoval V; Tariq N; Lampert R; Sinusas AJ; Liu YH
J Nucl Med; 2018 Apr; 59(4):652-658. PubMed ID: 28916622
[TBL] [Abstract][Full Text] [Related]
26. Variability in Heart-to-Mediastinum Ratio from Planar
Owenius R; Zanette M; Cella P
J Nucl Med Technol; 2017 Dec; 45(4):297-303. PubMed ID: 29042467
[TBL] [Abstract][Full Text] [Related]
27. Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging.
Okuda K; Nakajima K; Hosoya T; Ishikawa T; Konishi T; Matsubara K; Matsuo S; Kinuya S
J Nucl Cardiol; 2011 Feb; 18(1):82-9. PubMed ID: 21104360
[TBL] [Abstract][Full Text] [Related]
28. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology.
Flotats A; Carrió I; Agostini D; Le Guludec D; Marcassa C; Schäfers M; Somsen GA; Unlu M; Verberne HJ; ;
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(9):1802-12. PubMed ID: 20577740
[TBL] [Abstract][Full Text] [Related]
29. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
[TBL] [Abstract][Full Text] [Related]
30. 123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study.
Bax JJ; Kraft O; Buxton AE; Fjeld JG; Parízek P; Agostini D; Knuuti J; Flotats A; Arrighi J; Muxi A; Alibelli MJ; Banerjee G; Jacobson AF
Circ Cardiovasc Imaging; 2008 Sep; 1(2):131-40. PubMed ID: 19808530
[TBL] [Abstract][Full Text] [Related]
31. 123I-meta-iodobenzylguanidine in patients with chronic heart failure: technical aspects, conceptual issues, and future prospects.
Verberne HJ; Somsen GA; van Eck-Smit BL
Nucl Med Commun; 2009 Jun; 30(6):411-4. PubMed ID: 19417575
[No Abstract] [Full Text] [Related]
32. Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ( (123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout.
Verberne HJ; Somsen GA; Povinec P; van Eck-Smit BL; Jacobson AF
Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1322-8. PubMed ID: 19259662
[TBL] [Abstract][Full Text] [Related]
33. 123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials.
Jacobson AF; Lombard J; Banerjee G; Camici PG
J Nucl Cardiol; 2009; 16(1):113-21. PubMed ID: 19152136
[TBL] [Abstract][Full Text] [Related]
34. Cardiac neuronal imaging: application in the evaluation of cardiac disease.
Henneman MM; Bengel FM; van der Wall EE; Knuuti J; Bax JJ
J Nucl Cardiol; 2008; 15(3):442-55. PubMed ID: 18513651
[No Abstract] [Full Text] [Related]
35. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review.
Verberne HJ; Brewster LM; Somsen GA; van Eck-Smit BL
Eur Heart J; 2008 May; 29(9):1147-59. PubMed ID: 18349024
[TBL] [Abstract][Full Text] [Related]
36. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study.
Agostini D; Verberne HJ; Burchert W; Knuuti J; Povinec P; Sambuceti G; Unlu M; Estorch M; Banerjee G; Jacobson AF
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):535-46. PubMed ID: 18043919
[TBL] [Abstract][Full Text] [Related]
37. Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation.
Verberne HJ; Habraken JB; van Eck-Smit BL; Agostini D; Jacobson AF
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):547-53. PubMed ID: 17922122
[TBL] [Abstract][Full Text] [Related]
38. Neuronal imaging using SPECT.
Yamashina S; Yamazaki J
Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):939-50. PubMed ID: 17268772
[TBL] [Abstract][Full Text] [Related]
39. Imaging cardiac neuronal function and dysfunction.
Higuchi T; Schwaiger M
Curr Cardiol Rep; 2006 Mar; 8(2):131-8. PubMed ID: 16524540
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
